FHA
Flagship Harbor Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,073
| Closed | -$285K | – | 743 |
|
|
2024
Q3 | $285K | Buy |
+6,073
| New | +$285K | 0.02% | 575 |
|
|
2024
Q1 | $447K | Sell |
6,553
-43
| -0.7% | -$2.93K | 0.03% | 411 |
|
|
2023
Q4 | $413K | Buy |
6,596
+574
| +10% | +$35.9K | 0.03% | 405 |
|
|
2023
Q3 | $273K | Buy |
6,022
+209
| +4% | +$9.49K | 0.02% | 492 |
|
|
2023
Q2 | $326K | Buy |
5,813
+547
| +10% | +$30.7K | 0.03% | 450 |
|
|
2023
Q1 | $238K | Buy |
5,266
+200
| +4% | +$9.05K | 0.02% | 544 |
|
|
2022
Q4 | $206K | Buy |
5,066
+50
| +1% | +$2.03K | 0.02% | 566 |
|
|
2022
Q3 | $328K | Sell |
5,016
-36
| -0.7% | -$2.35K | 0.04% | 416 |
|
|
2022
Q2 | $307K | Sell |
5,052
-72
| -1% | -$4.38K | 0.03% | 452 |
|
|
2022
Q1 | $322K | Buy |
5,124
+233
| +5% | +$14.6K | 0.03% | 460 |
|
|
2021
Q4 | $371K | Buy |
4,891
+283
| +6% | +$21.5K | 0.04% | 442 |
|
|
2021
Q3 | $746K | Hold |
4,608
| – | – | 0.08% | 266 |
|
|
2021
Q2 | $746K | Buy |
4,608
+1,497
| +48% | +$242K | 0.08% | 267 |
|
|
2021
Q1 | $379K | Buy |
3,111
+46
| +2% | +$5.6K | 0.04% | 411 |
|
|
2020
Q4 | $469K | Buy |
3,065
+55
| +2% | +$8.42K | 0.06% | 327 |
|
|
2020
Q3 | $251K | Sell |
3,010
-690
| -19% | -$57.5K | 0.03% | 410 |
|
|
2020
Q2 | $271K | Buy |
3,700
+150
| +4% | +$11K | 0.04% | 382 |
|
|
2020
Q1 | $151K | Buy |
3,550
+883
| +33% | +$37.6K | 0.03% | 447 |
|
|
2019
Q4 | $162K | Sell |
2,667
-42
| -2% | -$2.55K | 0.03% | 483 |
|
|
2019
Q3 | $111K | Sell |
2,709
-600
| -18% | -$24.6K | 0.02% | 555 |
|
|
2019
Q2 | $155K | Hold |
3,309
| – | – | 0.03% | 458 |
|
|
2019
Q1 | $118K | Buy |
3,309
+600
| +22% | +$21.4K | 0.02% | 519 |
|
|
2018
Q4 | $77K | Buy |
2,709
+2,443
| +918% | +$69.4K | 0.02% | 591 |
|
|
2018
Q3 | $11K | Sell |
266
-100
| -27% | -$4.14K | ﹤0.01% | 1367 |
|
|
2018
Q2 | $21K | Buy |
+366
| New | +$21K | ﹤0.01% | 1072 |
|